Evidence map›Paper›PMID 19012745›Full record

ArticleJournal of neurochemistry2009

Muscarinic receptor regulation of osmosensitive taurine transport in human SH-SY5Y neuroblastoma cells.

Daniel J Foster, Victor M Vitvitsky, Ruma Banerjee, Anne M Heacock, Stephen K Fisher

Open access · greenAbstract read
In one paragraph

Article in Journal of neurochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Taurine biosynthesis by neurons and astrocytes.The Journal of biological chemistry · 2011
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Daniel J FosterDepartment of Pharmacology, University of Michigan, Ann Arbor, MI 48109-2200, USA.
Victor M Vitvitsky
Ruma Banerjee
Anne M Heacock
Stephen K Fisher
University of Michigan–Ann Arbor · US

Funding

INTERDEPARTMENTAL TRAINING IN PHARMACOLOGICAL SCIENCEST32GM007767 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ISOM, LORI L. · 1985 to 2019
$10.2M
The Sulfur/Glutamate Circuitry in the Neuroimmune SystemR01DK064959 · NIDDK · UNIVERSITY OF NEBRASKA LINCOLN · PI BANERJEE, RUMA V · 2003 to 2009
$2.2M
MUSCARINIC RECEPTOR COUPLING TO INOSITIDES IN CNSR01NS023831 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FISHER, STEPHEN K · 1986 to 2006
$2.2M
NIDDK NIH HHS DK 64959NIDDK NIH HHS R01 DK064959NIGMS NIH HHS GM 007767NIGMS NIH HHS T32 GM007767NINDS NIH HHS NS 23831NINDS NIH HHS R01 NS023831
6 · The paper itself

Abstract

The ability of G protein-coupled receptors to regulate osmosensitive uptake of the organic osmolyte, taurine, into human SH-SY5Y neuroblastoma cells has been examined. When monitored under isotonic conditions and in the presence of physiologically relevant taurine concentrations (1-100 microM), taurine influx was mediated exclusively by a Na(+)-dependent, high-affinity (K(m) = 2.5 microM) saturable transport mechanism (V(max) = 0.087 nmol/mg protein/min). Reductions in osmolarity of > 20% (attained under conditions of a constant NaCl concentration) resulted in an inhibition of taurine influx (> 30%) that could be attributed to a reduction in V(max), whereas the K(m) for uptake remained unchanged. Inclusion of the muscarinic cholinergic agonist, oxotremorine-M (Oxo-M), also resulted in an attenuation of taurine influx (EC(50) approximately 0.7 microM). Although Oxo-M-mediated inhibition of taurine uptake could be observed under isotonic conditions (approximately 25-30%), the magnitude of inhibition was significantly enhanced by hypotonicity (approximately 55-60%), a result that also reflected a reduction in the V(max), but not the K(m), for taurine transport. Oxo-M-mediated inhibition of taurine uptake was dependent upon the availability of extracellular Ca(2+) but was independent of protein kinase C activity. In addition to Oxo-M, inclusion of either thrombin or sphingosine 1-phosphate also attenuated volume-dependent taurine uptake. The ability of Oxo-M to inhibit the influx of taurine was attenuated by 4-[(2-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]butanoic acid, an inhibitor of the volume-sensitive organic osmolyte and anion channel. 4-[(2-Butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]butanoic acid also prevented receptor-mediated changes in the efflux and influx of K(+) under hypoosmotic conditions. The results suggest that muscarinic receptor activation can regulate both the volume-dependent efflux and uptake of taurine and that these events may be functionally coupled.

Indexed as

AlanineAntioxidantsBiological TransportCalciumCell Line, TumorCyclopentanesDose-Response Relationship, DrugEnzyme InhibitorsGuanidineHumansIndansLysophospholipidsMuscarinic AgonistsNeuroblastomaOsmolar ConcentrationOxotremorine4-(2-butyl-6,7-dichlor-2-cyclopentyl-indan-1-one-5-yl)oxybutyric acidAlanineAntioxidantsCalciumCyclopentanesEnzyme InhibitorsGuanidinehypotaurineIndansLysophospholipidsMuscarinic AgonistsOxotremorineoxotremorine MReceptors, MuscarinicSaline Solution, HypertonicSphingosinesphingosine 1-phosphateTaurineThapsigarginThrombinTritium

Identifiers

PMID19012745
PMCPMC2865146
OpenAlexW1996882271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.